RHUMBLINE ADVISERS - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$304
-99.7%
1,323
-97.8%
0.00%
Q1 2022$90,000
-28.0%
60,355
+5.0%
0.00%
Q4 2021$125,000
-44.2%
57,500
-8.7%
0.00%
Q3 2021$224,000
-41.8%
62,989
-6.1%
0.00%
-100.0%
Q2 2021$385,000
+45.3%
67,116
+31.5%
0.00%
Q1 2021$265,000
+136.6%
51,024
+8.4%
0.00%
Q4 2020$112,000
+138.3%
47,070
+38.3%
0.00%
Q3 2020$47,000
-33.8%
34,040
-8.2%
0.00%
Q2 2020$71,000
+61.4%
37,098
+108.1%
0.00%
Q1 2020$44,000
+10.0%
17,8300.0%0.00%
Q4 2019$40,000
+8.1%
17,8300.0%0.00%
Q3 2019$37,000
-17.8%
17,830
-1.1%
0.00%
Q2 2019$45,00018,0300.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders